Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - morphine sulphate - solution; injection - 10mg/ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - morphine sulphate - solution; injection - 15mg/1ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - pethidine hydrochloride - solution; injection - 100mg/2ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - pethidine hydrochloride - solution; injection - 50mg/ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - suxamethonium chloride - solution; injection - 100mg/2ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - theophylline ethylene diamine - solution; injection - 250mg/10ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - dexamethasone phoshate - injectable; injection - 4mg/1ml

Singapore - English - HSA (Health Sciences Authority)

pharma health care pte. ltd. - ophthalmology - relieves eye irritation due to particles such as dust or smoke.

Singapore - English - HSA (Health Sciences Authority)

pharma health care pte. ltd. - ophthalmology - moisturizes and refreshes tired and dry eyes.

European Union - English - EMA (European Medicines Agency)

teva pharma b.v.  - budesonide, formoterol fumarate dihydrate - asthma; pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - budesonide/formoterol teva pharma b.v. is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva pharma b.v. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:-in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.or-in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.copdsymptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev1)